Abstract
Acute kidney Injury (AKI) remains a diagnostic and therapeutic dilemma. Translation of excellent basic science information into therapeutic advances in AKI now depends on early diagnosis and drug delivery before elimination of the potential for this target to influence cell injury. For instance,
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have